Day: February 16, 2022

Palm Coast, FL, Feb. 16, 2022 (GLOBE NEWSWIRE) — Gold River Productions, Inc. (OTC Pink: GRPS) announces the appointment of Defense Aerospace engineer and executive Dr. Gabe Vlad as Chief Technical Officer. Dr. Vlad brings outstanding skills and experience to Gold River including vast dealings with government and commercial contracts for advanced research/engineering, business/manufacturing/production and intellectual property levels and will be actively involved in algorithm development, science and engineering research and monetization of Gold River.  Additionally, Dr. Vlad’s current and past government contract experience adds a new and rare dimension to our government initiatives. “Dr. Vlad was the missing link to our platform at Gold River,” explains Chairman of the Board, Richard Goulding, M.D.  “I am so excited to...

Finnvera Group, Stock Exchange Release 16 February 2022 Finnvera Group’s Report of the Board of Directors and Financial Statements 2021 Domestic financing remained at a high level while export financing grew – Finnvera Group made a profit of EUR 153 million Finnvera Group, summaryResult 153 MEUR (-748) – no new significant loss provisions had to be made, and no material final losses were realised – however, there were no grounds for decreasing the credit loss provisions made in 2020. Profit by segment: profit of the parent company Finnvera plc’s SME and midcap business stood at 34 MEUR (87) and that of Large Corporates business at 73 MEUR (-848); the subsidiaries’ impact on the Group’s result was 45 MEUR (13). Separate result for export credit guarantee and special guarantee operations: 79 MEUR (-829). Balance sheet total: EUR 12.2...

VANCOUVER, British Columbia, Feb. 16, 2022 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT) (OTCPink:RQHTF) (FSE:MHN2), a rapidly growing global telemedicine company developing innovative Virtual Care solutions for the multibillion-dollar Healthcare market, is capitalizing on recent changes to the Centers for Medicare and Medicaid Services billing schedules to add a significant number of new patients to its platform. The new physician fee schedule that came into effect on January 1st, extends the services offered to patients with musculoskeletal or respiratory conditions by adding five new Remote Therapeutic Monitoring/Treatment Management codes that are now covered by CMS. Reliq Health has signed implementation plan arrangements with current clients and anticipates onboarding more than 10,000 new Remote Therapeutic...

VANCOUVER, British Columbia, Feb. 16, 2022 (GLOBE NEWSWIRE) — Blender Bites Ltd. (the “Company”, “Blender Bites” or “Blender”), (CSE: BITE, FWB: JL40, WKN: A3DWAM), a Canadian company that develops and markets a line of premium, organic and plant-based pre-portioned frozen functional foods, announces record sales revenues in January of 2022, representing more than a 3000% increase compared to the same period in 2021, as well as the Company’s highest monthly revenue on record. Founded in 2016, Blender Bites became the first company to produce a pre-portioned smoothie puck in the Canadian market and its one step smoothie product line can be found in more than 850 retail stores across Canada and the US. In January of 2022, the Company saw total revenues of $560,654 CAD with related expenses of $416,238. This represents a significant...

Press Release – February 16, 2022   Sébastien Metzger appointed General Counsel M&A and Finance of Wendel Wendel is pleased to announce today the appointment of Sébastien Metzger as General Counsel M&A and Finance of Wendel. In this capacity, he will join Wendel’s Coordination Committee. A lawyer by training, Sébastien Metzger, 41, began his career at Wendel in 2008 as an M&A lawyer and was promoted to Deputy Head of Legal Affairs in January 2018. During these years, Sébastien has participated in the majority of transactions carried out by Wendel, whether they were unlisted private transactions, market transactions or debt transactions (bond issues) during which he acquired a solid experience in the French and American M&A markets. He has also been regularly involved in portfolio development transactions.  Sébastien...

MANAGEMENT COMMENTARY 2021 is over and with it also marks the end of Finnish saga. As disclosed, we have sale agreement of 100% shares of Heimon Kala Oy. Even if to consider slight improvement in group operational EBITDA, it was clear that without consolidation it would have been challenging for Heimon Kala Oy to remain an independent company. Multiple management mistakes and constant sale of private label products below cost price, led to decision that selling Heimon Kala Oy is rational decision rather than to keep restructuring and recapitalizing the business. The origin of losses in Finland is the incompetence of Finnish management in 2020 and 2021 to price products and manage cost base. Private label prices offered at the end of 2020 and beginning to 2021 (the pricing cycle in Finland is 6 months forward), didn´t not match raw material...

Press release, Helsinki, 16 February 2022 at 9:30 AM (EET) Nexstim Receives a System Upgrade Order from a Customer in Finland Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) has received an NBS 5 system upgrade order from a customer in Finland. Nexstim’s NBS (Navigated Brain Stimulation) system can be used, for example, in planning neurosurgery or radiation therapy after a patient has had a diagnosis of a brain tumor or other disorder. The NBS system is CE marked for pre-surgical mapping of the speech and motor cortices of the brain. This specific NBS system also includes the software of an NBT® (Navigated Brain Therapy) system, allowing the system to also be used for therapeutic treatments. Mikko Karvinen, CEO of Nexstim, comments: “We are happy to announce this sale to one of our existing customers...

QPR SOFTWARE, STOCK EXCHANGE RELEASE, FEBRUARY 16, 2022 AT 9:30 AMNet sales at the same level as 2020, operating result decreased, but strategically important SaaS business showed clear growth. January – December 2021SaaS business grew by 19%. Net sales amounted to EUR 9,140 thousand (2020: 8,971) and grew by 2%. EBITDA was EUR 241 thousand (248). Operating result (EBIT) was EUR -1,248 thousand (-936). Result before taxes was EUR -1,356 thousand (-952). Result for the period was EUR -1,356 thousand (-812). Earnings per share was EUR -0.113 (-0.068). Operating result was weakened by write-downs worth EUR 373 thousand made in connection with preparing financial statements.October – December 2021SaaS business grew by 28%. Net sales were EUR 2,054 thousand (2020: 2,341) and decreased by 12%. EBITDA was EUR -430 thousand (27). Operating...

Aspo Plc Financial Statement Release               February 16, 2022, at 9:30 am Aspo Group financial statement release, January 1 to December 31, 2021 The highest full-year operating profit in Aspo’s history Figures from the corresponding period in 2020 are presented in brackets. October–December 2021, continuing operationsAspo’s net sales increased by 27% to EUR 160.0 (125.6) million. Operating profit stood at EUR 8.7 (6.7) million. The operating profit rate was 5.4% (5.3%). The Group’s combined operating profit, also including the operating profit of EUR 0.1 million of Kauko, which has been classified as a discontinued operation, was EUR 8.8 (7.6) million. * Earnings per share increased to EUR 0.17 (0.15). The operating profit of ESL Shipping was EUR 9.8 (4.8) million, Telko EUR 4.4 (3.2) million, and Leipurin EUR -3.6 (0.2) million. Net...